Cognitive dysfunction in multiple sclerosis: A review of recent developments

Current Opinion in Neurology

Volumn 16, Issue 3, 2003, Pages 283-288

  Bobholz, Julie A ^a   Rao, Stephen M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cognition; Multiple sclerosis; Neuroimaging

Indexed keywords

BETA1 INTERFERON; INTERFERON BETA SERINE;

COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMYELINATION; DISEASE ACTIVITY; DRIVING ABILITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ACTIVITIES OF DAILY LIVING; COGNITION; COGNITION DISORDERS; EMOTIONS; HUMANS; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 0037782268     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200306000-00006     Document Type: Review

References (33)

1. Thornton AE, Raz N, Tucker KA. Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 2002; 8:395-409. This study addressed the debate regarding encoding versus retrieval deficits in multiple sclerosis. The authors systematically examined these components of memory by evaluating the efficacy of encoding under varied conditions.
2. Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ. A comparison of memory performance in relapsing - remitting, primary progressive and secondary progressive multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:32-44.
3. Seinela A, Hamalainen P, Koivisto M, Ruutiainen J. Conscious and unconscious uses of memory in multiple sclerosis. J Neurol Sci 2002; 198:79-85. The results from this study supported previous findings suggesting that implicit memory skills are generally preserved in multiple sclerosis.
4. Janculjak D, Mubrin Z, Brinar V, Spilich G. Changes of attention and memory in a group of patients with multiple sclerosis. Clin Neurol Neurosurg 2002; 104:221-227.
5. Kenealy PM, Beaumont JG, Lintern TC, Murrell RC. Autobiographical memory in advanced multiple sclerosis: assessment of episodic and personal semantic memory across three time spans. J Int Neuropsychol Soc 2002; 8:855-860. The results of this study suggested that 60% of the multiple sclerosis sample showed deficits in autobiographical memory, with a level of impairment associated with general cognitive ability. Episodic features of autobiographical information were more susceptible to decline than semantic autobiographical information.
6. Fisk JD, Archibald CJ. Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. J Int Neuropsychol Soc 2001; 7:363-372.
7. Pujol J, Vendrell P, Deus J, et al. The effect of medial frontal and posterior parietal demyelinating lesions on Stroop interference. Neuroimage 2001; 13:68-75.
8. de Sonneville LM, Boringa JB, Reuling IEW, et al. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002; 40:1751-1765. This study presented data regarding processing speed across subtypes of multiple sclerosis. Results suggested that multiple sclerosis patients are 40% slower than control subjects on tasks of processing speed. Patients with progressive course were significantly slower than those with relapsing - remitting course.
9. Arnett PA, Higginson CI, Randolph JJ. Depression in multiple sclerosis: relationship to planning ability. J Int Neuropsychol Soc 2001; 7:665-674.
10. Laatu S, Revonsuo A, Hamalainen P, et al. Visual object recognition in multiple sclerosis. J Neurol Sci 2001; 185:77-88.
11. Vleugels L, Lafosse C, van Nunen A, et al. Visuoperceptual impairment in MS patients: nature and possible neural origins. Mult Scler 2001; 7:389-401.
12. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 58:1602-1606.
13. Lings S. Driving accident frequency increased in patients with multiple sclerosis. Acta Neurol Scand 2002; 105:169-173.
14. Shawaryn MA, Schultheis MT, Garay E, DeLuca J. Assessing functional status: exploring the relationship between the Multiple Sclerosis Functional Composite and driving. Arch Phys Med Rehabil 2002; 83:1123-1129. This article, as well as others recently published, emphasizes the importance of safety while driving among multiple sclerosis patients.
15. Schultheis MT, Garay E, Millis SR, DeLuca J. Motor vehicle crashes and violations among drivers with multiple sclerosis. Arch Phys Med Rehabil 2002; 83:1175-1178.
16. Schultheis MT, Garay E, DeLuca J. The influence of cognitive impairment on driving performance in multiple sclerosis. Neurology 2001; 56:1089-1094.
17. Benedict RHB, Priore RL, Miller C, et al. Personality disorder in MS correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001; 13:70-76.
18. Heesen C, Gold SM, Raji A, et al. Cognitive impairment correlates with hypothalamo - pituitary - axis dysregulation in multiple sclerosis. Psychoneuroendocrinology 2002; 27:505-517.
19. Edwards SGM, Liu C, Blumhardt LD. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis. Acta Neurol Scand 2001; 104:214-223.
20. Sperling RA, Guttmann CR, Hohol MJ, et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001; 58:115-121.
21. Bermel RA, Bakshi R, Tjoa C, et al. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002; 59:275-280. This study correlated degree of cognitive dysfunction with various measurements of MRI neuropathology. Bicaudate ratio correlated more closely with cognitive performance than other measures (whole brain atrophy and lesion volume).
22. Benedict RH, Bakshi R, Simon J, et al. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2002; 14:44-51. Based on the findings of this study, the authors suggested use of atrophy measurements when examining correlates of cognitive dysfunction.
23. Nocentini U, Rossini PM, Carlesimo GA, et al. Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings. European Neurology 2001; 45:11-18.
24. Ciccarelli O, Brex PA, Thompson A, Miller DH. Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J Neurol 2002; 249:18-24.
25. Zivadinov R, De Masi R, Nasuelli D, et al. MRI techniques and cognitive impairment in the early phase of relapsing - remitting multiple sclerosis. Neuroradiology 2001; 43:272-278.
26. Rovaris M, Iannucci G, Falautano M, et al. Cognitive dysfunction in patients with mildly disabling relapsing - remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002; 195:103-109. The authors examined the relationships between diffusion tensor MRI and cognitive performances in a sample of multiple sclerosis patients with relapsing - remitting course.
27. Rocoa MA, Falini A, Columbo B, et al. Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 2002; 51:330-339.
28. Staffen W, Mair A, Zauner H, et al. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 2002; 125:1275-1282.
29. Patzold T, Schwengelbeck M, Ossege LM, et al. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 2002; 105:164-168. Data are presented suggesting improved MSFC scores with methylprednisolone treatment during a 20-day interval.
30. Gillson G, Richard TL, Smith RB, Wright JV. A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis. Mult Scler 2002; 8:30-35.
31. Rossini PM, Pasqualetti P, Pozzilli C, et al. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 2001; 7:354-358.
32. Fischer JS, Priore RL, Jacobs LD, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000; 48:885-892.
33. Barak Y, Achiron A. Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 2002; 47:11-14. Although sample size is relatively small, this study demonstrated significant cognitive improvement on cognitive measures among those treated with interferon β-1b. In contrast, the control group showed some deterioration on cognitive measures and no significant improvement.